Table 3. Detailed information about the patients with recurrent breast cancers and positive FDG-PET/CT findings.

Case	Age (year)	CA 15-3 (ng/ml)	Stage	First treatment	FDG-PET/CT findings	SUVmax
1	55	44.7	I	BCT	Chest wall, LN, lung, liver, bone.	17.5
2	46	36	II	MRM	Mediastinal LN	4.7
3	60	40	III	MRM	Bone	6.1
4	55	98	II	MRM	Internal mammary chain	2.3
5	46	145.5	II	MRM	Chest wall, LN, bone	15.3
6	33	33.3	I	SSM+TRAM	Lung, LN	13.6
7	34	35.8	II	MRM	LN	3.9
8	36	33.1	II	MRM	Chest wall (a 0.7 cm nodule)	1.4
9	75	33	III	MRM	Bone	4.8
10	57	60.4	III	MRM	Liver	5.7
11	47	1329	II	MRM	Lung, bone	14.8
12	57	32.3	II	MRM	Bone	7.6
13	55	52.4	III	MRM	Bone	5.6
14	38	38.4	II	SSM+TRAM	Chest wall, LN	4.3
15	39	55.8	III	SSM+TRAM	Chest wall, LN, liver	17.5
16	68	43.4	III	MRM	Bone	3.5
17	77	31.4	III	MRM	Chest wall, LN, lung	4.1
18	45	34.3	II	MRM	Chest wall, LN, bone	11.2
19	50	27	II	MRM	Chest wall, LN, bone	7.7
20	57	18.9	III	MRM	Chest wall, LN	20.6
21	84	18.9	II	MRM	LN, lung, adrenal gland	6.8
22	70	19.6	II	MRM	LN, lung, liver	10.8
23	47	16.1	II	MRM	Chest wall, LN	8.2
24	43	21	I	Lumpectomy+ALND	Chest wall	23.2
25	38	12.7	II	SSM+TRAM	LN (a 1.1 cm axillary node)	4.7
26	43	2.1	II	SSM+TRAM	LN, lung, bone	8.1
27	48	10.1	III	MRM	Liver	2.9
28	40	7.9	I	BCT	Chest wall	3.8
29	68	14.1	II	MRM	Chest wall (a 0.8 cm nodule)	2.3
30	63	7.1	II	MRM	LN	18.2
31	76	10.6	II	MRM	Chest wall, LN	12.1
32	60	19.5	I	MRM	LN, lung	9.9
33	60	7.5	II	Partial mastectomy	LN	9.1
34	62	9.2	II	BCT	Chest wall, LN	4
35	58	16.6	II	MRM	Lung	2.6
36	42	8.4	II	MRM	LN	3.2
37	45	20.9	I	Partial mastectomy+ALND	Pleura	2.3
38	49	23.6	0	Excision	LN	3.4
39	55	10.5	III	MRM	LN, bone	4.1
40	81	23.1	III	MRM	Lung	3.3
41	46	5.8	III	SSM+TRAM	LN	7.7
42	59	21.8	I	BCT	LN, bone, lung	6.8

ALND: axillary lymph node dissection; BCT: breast conserving therapy; LN, lymph node; MRM: modified radical mastectomy; SSM+TRAM: skin-sparing mastectomy and transverse rectus abdominus myocutaneous; SUV, standardized uptake value.